Tessara Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$10M
Tessara Therapeutics General Information
Description
Developer of three-dimensional (3D) neural micro-tissues intended for therapeutic and drug screening applications. The company's tissue aims to replace inadequate and expensive existing cell and animal models and is designed to secrete therapeutic factors to address key deficiencies associated with Parkinson's disease pathophysiology and other neurological diseases, enabling the medical community to reduce costs and failures in neuroscience drug development to date.
Contact Information
Website
www.tessaratherapeutics.comCorporate Office
- 566 Street Kilda Road
- Suite 103
- Melbourne, Victoria 3004
- Australia
Corporate Office
- 566 Street Kilda Road
- Suite 103
- Melbourne, Victoria 3004
- Australia
Tessara Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 28-Mar-2022 | $10M | Completed | Generating Revenue | ||
| 1. Angel (individual) | 07-May-2020 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Tessara Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tessara Therapeutics Patents
Tessara Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025900783-A0 | Integrated biosensor compositions and methods | Pending | 13-Mar-2025 | ||
| AU-2024903364-A0 | Improved cellularised hydrogel compositions and related methods | Pending | 18-Oct-2024 | ||
| AU-2024900695-A0 | Integrated biosensor compositions and methods | Pending | 15-Mar-2024 | ||
| AU-2023903346-A0 | Improved cellularised hydrogel compositions and related methods | Pending | 20-Oct-2023 | ||
| AU-2022903108-A0 | Improved cellularised hydrogel compositions and related methods | Pending | 21-Oct-2022 |
Tessara Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tessara Therapeutics FAQs
-
When was Tessara Therapeutics founded?
Tessara Therapeutics was founded in 2018.
-
Where is Tessara Therapeutics headquartered?
Tessara Therapeutics is headquartered in Melbourne, Australia.
-
What is the size of Tessara Therapeutics?
Tessara Therapeutics has 9 total employees.
-
What industry is Tessara Therapeutics in?
Tessara Therapeutics’s primary industry is Drug Discovery.
-
Is Tessara Therapeutics a private or public company?
Tessara Therapeutics is a Private company.
-
What is Tessara Therapeutics’s current revenue?
The current revenue for Tessara Therapeutics is .
-
How much funding has Tessara Therapeutics raised over time?
Tessara Therapeutics has raised $12.7M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
